scholarly article | Q13442814 |
P50 | author | Reese H Clark | Q39492406 |
Michael Cohen-Wolkowiez | Q93049830 | ||
P2093 | author name string | P Brian Smith | |
Christoph P Hornik | |||
Matthew M Laughon | |||
Debbie Avant | |||
Nidhi Tripathi | |||
William Rodriguez | |||
P2860 | cites work | Innovative clinical trial design for pediatric therapeutics | Q24635308 |
Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia | Q31805892 | ||
Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia | Q32157061 | ||
Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. | Q33705707 | ||
Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates | Q33983697 | ||
Metoclopramide, H2 blockers, and proton pump inhibitors: pharmacotherapy for gastroesophageal reflux in neonates | Q34030734 | ||
Developmental pharmacology--drug disposition, action, and therapy in infants and children | Q34247047 | ||
Inhaled nitric oxide in preterm infants undergoing mechanical ventilation | Q34551446 | ||
Early inhaled nitric oxide therapy in premature newborns with respiratory failure | Q34551453 | ||
Unlicensed and off-label drug use in an Australian neonatal intensive care unit | Q34988031 | ||
Early initiation of lopinavir/ritonavir in infants less than 6 weeks of age: pharmacokinetics and 24-week safety and efficacy | Q35222977 | ||
Clinical safety of moxifloxacin ophthalmic solution 0.5% (VIGAMOX) in pediatric and nonpediatric patients with bacterial conjunctivitis | Q36300569 | ||
Changing patterns of drug utilization in a neonatal intensive care population | Q36519127 | ||
NIH consensus development conference: Inhaled nitric oxide therapy for premature infants | Q37806069 | ||
Early dexamethasone therapy in preterm infants: a follow-up study | Q42542989 | ||
A trial of three antiretroviral regimens in HIV-1-infected children | Q42629119 | ||
HES 130/0.4 (Voluven) or human albumin in children younger than 2 yr undergoing non-cardiac surgery. A prospective, randomized, open label, multicentre trial | Q42648259 | ||
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease | Q42696550 | ||
Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD). | Q43122470 | ||
The safety and efficacy of sevoflurane anesthesia in infants and children with congenital heart disease | Q43589027 | ||
Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hours | Q43673455 | ||
A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. I. Emergence and recovery profiles | Q43810968 | ||
A randomized multicenter study of remifentanil compared with halothane in neonates and infants undergoing pyloromyotomy. II. Perioperative breathing patterns in neonates and infants with pyloric stenosis | Q43810972 | ||
Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia | Q43985373 | ||
Famotidine for infant gastro‐oesophageal reflux: a multi‐centre, randomized, placebo‐controlled, withdrawal trial | Q44444407 | ||
Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children | Q44546116 | ||
Impact of ontogeny on linezolid disposition in neonates and infants | Q44637316 | ||
Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life | Q44960395 | ||
Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial | Q45025783 | ||
Pharmacokinetics and antiretroviral activity of lamivudine alone or when coadministered with zidovudine in human immunodeficiency virus type 1-infected pregnant women and their offspring | Q45753331 | ||
Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease. | Q46037136 | ||
THE EFFECTS OF TETRACYCLINES UPON THE DENTITION. | Q46288999 | ||
Age-dependent pharmacokinetics of lansoprazole in neonates and infants | Q46510339 | ||
Safety and pharmacodynamics of lansoprazole in patients with gastroesophageal reflux disease aged <1 year | Q46510346 | ||
Changing pattern of drug utilization in a neonatal intensive care unit | Q71225017 | ||
[The incidence of prescriptions without marketing product license in a neonatal intensive care unit] | Q73507020 | ||
Pharmacokinetics and pharmacodynamics of famotidine in infants | Q73746962 | ||
A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic antibacterial regimens | Q74267298 | ||
Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation | Q74592727 | ||
A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital | Q77123451 | ||
Fatal circulatory collapse in premature infants receiving chloramphenicol | Q79179771 | ||
Pediatric information in drug product labeling | Q84092390 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 130-136 | |
P577 | publication date | 2014-02-01 | |
P1433 | published in | JAMA Pediatrics | Q4787306 |
P1476 | title | Drug labeling and exposure in neonates | |
P478 | volume | 168 |
Q38480753 | A Survey of Neonatal Pharmacokinetic and Pharmacodynamic Studies in Pediatric Drug Development |
Q54194778 | Advances in Pediatric Pharmacology, Therapeutics, and Toxicology. |
Q33998667 | Advances in pediatric pharmacology, therapeutics, and toxicology |
Q39147483 | Age-Dependent Absolute Abundance of Hepatic Carboxylesterases (CES1 and CES2) by LC-MS/MS Proteomics: Application to PBPK Modeling of Oseltamivir In Vivo Pharmacokinetics in Infants |
Q42019687 | An Algorithm to Identify Compounded Non-Sterile Products that Can Be Formulated on a Commercial Scale or Imported to Promote Safer Medication Use in Children |
Q28088630 | Anesthetic use in newborn infants: the urgent need for rigorous evaluation |
Q90298395 | Assessing CYP2C19 Ontogeny in Neonates and Infants Using Physiologically Based Pharmacokinetic Models: Impact of Enzyme Maturation Versus Inhibition |
Q88816139 | Association of Early Inhaled Nitric Oxide With the Survival of Preterm Neonates With Pulmonary Hypoplasia |
Q90178818 | Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research |
Q36887756 | Clindamycin Pharmacokinetics and Safety in Preterm and Term Infants |
Q47917646 | Collaboration in Regulatory Science to Facilitate Therapeutic Development for Neonates |
Q34458246 | Comparative effectiveness of digoxin and propranolol for supraventricular tachycardia in infants |
Q38649419 | Dosing antibiotics in neonates: review of the pharmacokinetic data |
Q34716879 | Dosing in neonates: special considerations in physiology and trial design |
Q36776390 | Drug-induced acute kidney injury in neonates |
Q26849339 | Drug-induced renal damage in preterm neonates: state of the art and methods for early detection |
Q38263730 | Ethics of drug studies in the newborn. |
Q38965300 | How to optimise drug study design: pharmacokinetics and pharmacodynamics studies introduced to paediatricians. |
Q90208079 | International Coherence of Pediatric Drug Labeling for Drug Safety: Comparison of Approved Labels in Korea and the United States |
Q54240649 | Large differences in neonatal drug use between NICUs are common practice: time for consensus? |
Q57156418 | Maternal and environmental risk factors for neonatal AKI and its long-term consequences |
Q36652800 | Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks |
Q47304205 | Methodological and Ethical Issues in Pediatric Medication Safety Research |
Q38626545 | Neonatal Safety Information Reported to the FDA During Drug Development Studies |
Q26780200 | Neonatal anesthesia: how we manage our most vulnerable patients |
Q38469763 | Neonatal medicines research: challenges and opportunities |
Q53798658 | Newborns still lack drug data to guide therapy. |
Q40405030 | Off-label and unlicensed drug treatments in Neonatal Intensive Care Units: an Italian multicentre study |
Q38215682 | Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants. |
Q38696468 | Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates |
Q48076685 | Physiologically Based Pharmacokinetic Prediction of Linezolid and Emtricitabine in Neonates and Infants |
Q94544639 | Precision Dosing Priority Criteria: Drug, Disease, and Patient Population Variables |
Q30938796 | Predicting neonatal pharmacokinetics from prior data using population pharmacokinetic modeling |
Q47428031 | Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates |
Q34628384 | Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons |
Q90726651 | Surfactant Administration in Preterm Infants: Drug Development Opportunities |
Q38222870 | Tailored tools to improve pharmacotherapy in infants |
Q87434784 | The EU paediatric regulation: still a large discrepancy between therapeutic needs and approved paediatric investigation plans |
Q38265444 | The principle of equipoise in pediatric drug trials. |
Q92206554 | Timing of Pediatric Drug Approval and Clinical Evidence Submitted to Regulatory Authorities: International Comparison Among Japan, the United States, and the European Union |
Search more.